Counterpoint: should thoracoscopic talc pleurodesis be the first choice management for malignant pleural effusion? No
- PMID: 22796835
- DOI: 10.1378/chest.12-1087
Counterpoint: should thoracoscopic talc pleurodesis be the first choice management for malignant pleural effusion? No
Comment in
-
Management of recurrent malignant pleural effusions: an ever-recurring issue?Chest. 2012 Dec;142(6):1696. doi: 10.1378/chest.12-2038. Chest. 2012. PMID: 23208361 No abstract available.
Comment on
-
Point: Should thoracoscopic talc pleurodesis be the first choice management for malignant effusion? Yes.Chest. 2012 Jul;142(1):15-17. doi: 10.1378/chest.12-1085. Chest. 2012. PMID: 22796834 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
